Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOON: S-1 with TACE and HAIC-OXA for Advanced HCC
NCT01997957Phase 4Unknown
- Start
- Oct 2013
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tegafur in hepatocellular carcinoma (HCC). Status: unknown.
02
Drugs
tegafur
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01997957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01997957.